Annals of medicine and surgery (2012)
Sunvozertinib in EGFR exon 20 insertion-mutated non-small cell lung cancer: expanding targeted therapy beyond standard EGFR inhibitors: a correspondence.
Ehtisham Haider, Iqra Akhtar, Javeria Taj, Joshua Ekouo
Published: 202510.1097/MS9.0000000000004137
No abstract available for this study.